Nanoscience for Drug Delivery in Diabetes
- Authors: N. Vishal Gupta1, K. Trideva Sastri2, M. Sharadha3, Souvik Chakraborty4, Hitesh Kumar5, Vikas Jain6, Surajit Dey7
-
View Affiliations Hide Affiliations1 Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India 2 Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India 3 Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India 4 Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India 5 Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India 6 Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India 7 Roseman University of Health Sciences, College of Pharmacy, Henderson, Nevada, USA
- Source: Nanoscience Applications in Diabetes Treatment , pp 70-101
- Publication Date: December 2023
- Language: English
Nanoscience for Drug Delivery in Diabetes, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9789815196535/chapter-4-1.gif
Current conventional diabetes mellitus (DM) therapies are inadequate and have poor patient compliance. Subsequently, it is necessary to explore nanomedicine in managing diabetes. In recent years, several nanocarrier systems have been proven effective in various aspects of diabetes treatment, increasing drug stability, overcoming different biological barriers, and in enhancing bioavailability. Nanomedicine can potentially improve the therapeutic effect of drug substances to gain the patient's belief and impart a greater level of acceptability. In the present scientific spectrum, nanomedicines promise to provide sustained and targeted delivery with potential physical stability for a prolonged period, rendering a safe and effective therapy for diabetes. This chapter comprehensively elaborates on trends in the drug delivery system in treating diabetes for improved delivery of different classes of antidiabetic agents compared to contemporary therapies.
-
From This Site
/content/books/9789815196535.chapter-4dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
